BDNF-AS is a promising downregulated biomarker for the diagnosis in different disease types in multiple sclerosis
Preprint in Research Square (September 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Preprint in Research Square (September 2022)
Article in Multiple Sclerosis and Related Disorders (March 2022)
Article in Immunology and Allergy Science and Practice (April 2020)